These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32279670)

  • 61. Reduced Clostridioides difficile Tests Among Solid Organ Transplant Recipients Through a Diagnostic Stewardship Bundled Intervention.
    Madden GR; Sifri CD
    Ann Transplant; 2019 May; 24():304-311. PubMed ID: 31133632
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Characteristics of Clostridium difficile infection in patients with discordant diagnostic test results.
    Ramos Martínez A; Ortiz Balbuena J; Asensio Vegas Á; Sánchez Romero I; Múñez Rubio E; Cantero Caballero M; Cózar Llistó A; Portero Azorín F; Martínez Ruiz R
    Rev Esp Enferm Dig; 2016 Jun; 108(6):304-8. PubMed ID: 27033878
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Toxin B PCR Amplification Cycle Threshold Adds Little to Clinical Variables for Predicting Outcomes in
    Origüen J; Orellana MÁ; Fernández-Ruiz M; Corbella L; San Juan R; Ruiz-Ruigómez M; López-Medrano F; Lizasoain M; Ruiz-Merlo T; Maestro-de la Calle G; Parra P; Villa J; Delgado R; Aguado JM
    J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30463889
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil.
    Maestri AC; Raboni SM; Morales HMP; Ferrari LF; Tuon FFB; Losso A; Marconi C; Nogueira KDS
    Anaerobe; 2020 Aug; 64():102238. PubMed ID: 32717474
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Trends in Clostridioides difficile diagnosis before and after a change in testing algorithm.
    Turner DP; Thorburn SJ; Crowe A; Jardine D; Timmins C
    J Microbiol Methods; 2021 May; 184():106189. PubMed ID: 33689797
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact of toxigenic Clostridium difficile polymerase chain reaction testing on the clinical microbiology laboratory and inpatient epidemiology.
    Napierala M; Munson E; Skonieczny P; Rodriguez S; Riederer N; Land G; Luzinski M; Block D; Hryciuk JE
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):534-8. PubMed ID: 23731555
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Detection of toxigenic Clostridioides [Clostridium] difficile: Usefulness of two commercially available enzyme immunoassays and a PCR assay on stool samples and stool isolates.
    Legaria MC; Rollet R; Di Martino A; Castello L; Barberis C; Rossetti MA; Guardati MC; Fernández Canigia L; Carloni G; Litterio M; Rocchi M; Anchart EG; Trejo FM; Minnaard J; Klajn D; Predari SC
    Rev Argent Microbiol; 2018; 50(1):36-44. PubMed ID: 28988901
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical and Microbiologic Assessment of Cases of Pediatric Community-associated Clostridium difficile Infection Reveals Opportunities for Improved Testing Decisions.
    Kociolek LK; Patel SJ; Zheng X; Todd KM; Shulman ST; Gerding DN
    Pediatr Infect Dis J; 2016 Feb; 35(2):157-61. PubMed ID: 26517329
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diagnosis and management of paediatric Clostridioides difficile infection in a tertiary centre: A prospective audit.
    Gates V; Best E; Roberts S; Swager T; Voss L
    J Paediatr Child Health; 2021 Apr; 57(4):500-506. PubMed ID: 33145899
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.
    Kelly CP; Chen X; Williams D; Xu H; Cuddemi CA; Daugherty K; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
    Clin Infect Dis; 2020 Mar; 70(6):1083-1093. PubMed ID: 31211839
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prevalence, characteristics and antimicrobial susceptibility patterns of Clostridioides difficile isolated from hospitals in Iran.
    Alimolaei M; Rahimi HR; Ezatkhah M; Shamsaddini Bafti M; Afzali S
    J Glob Antimicrob Resist; 2019 Dec; 19():22-27. PubMed ID: 30825696
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The association of a reduced susceptibility to moxifloxacin in causative Clostridium (Clostridioides) difficile strain with the clinical outcome of patients.
    Krutova M; Capek V; Nycova E; Vojackova S; Balejova M; Geigerova L; Tejkalova R; Havlinova L; Vagnerova I; Cermak P; Ryskova L; Jezek P; Zamazalova D; Vesela D; Kucharova A; Nemcova D; Curdova M; Nyc O; Drevinek P
    Antimicrob Resist Infect Control; 2020 Jun; 9(1):98. PubMed ID: 32605598
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ultrasensitive Clostridioides difficile Toxin Testing for Higher Diagnostic Accuracy.
    Sandlund J; Davies K; Wilcox MH
    J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32269098
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effectiveness of a Two-Step Testing Algorithm for Reliable and Cost-Effective Detection of Clostridium difficile Infection in a Tertiary Care Hospital in Saudi Arabia.
    Qutub M; Govindan P; Vattappillil A
    Med Sci (Basel); 2019 Jan; 7(1):. PubMed ID: 30626129
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diagnostic stewardship of Clostridioides difficile polymerase chain reaction results from syndromic diarrhea panel and implications for patient outcomes.
    Wadskier F; Cowman K; Szymczak WA; Weston G; Guo Y; Bartash R; Levi MH; Nori P
    Diagn Microbiol Infect Dis; 2020 Jun; 97(2):115032. PubMed ID: 32299633
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Improving Appropriate Diagnosis of
    Liu C; Lan K; Krantz EM; Kim HN; Zier J; Bryson-Cahn C; Chan JD; Jain R; Lynch JB; Pergam SA; Pottinger PS; Sweet A; Whimbey E; Bryan A
    Open Forum Infect Dis; 2020 Oct; 7(10):ofaa366. PubMed ID: 33094113
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cost Consequences for the NHS of Using a Two-Step Testing Method for the Detection of
    Jones WS; Rice S; Power HM; Maniatopoulos G; Suklan J; Beyer F; Wilcox MH; Permain M; Simpson AJ; Price DA; Allen AJ
    Diagnostics (Basel); 2020 Oct; 10(10):. PubMed ID: 33066456
    [No Abstract]   [Full Text] [Related]  

  • 78. Molecular-based diagnosis of Clostridium difficile infection is associated with reduced mortality.
    Avni T; Babich T; Ben-Zvi H; Atamna A; Yahav D; Shepshelovich D; Leibovici-Weissman Y; Bishara J
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1137-1142. PubMed ID: 29627950
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation of Risk Factors for Clostridium difficile Infection Based on Immunochromatography Testing and Toxigenic Culture Assay.
    Ohshima T; Osaki T; Yamamoto Y; Asai S; Miyachi H; Kamiya S
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30232129
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Can a toxin gene NAAT be used to predict toxin EIA and the severity of
    Garvey MI; Bradley CW; Wilkinson MAC; Holden E
    Antimicrob Resist Infect Control; 2017; 6():127. PubMed ID: 29270290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.